Navigation Links
Genes Influence Whether Psych Drugs Lead to Weight Gain
Date:7/20/2012

FRIDAY, July 20 (HealthDay News) -- Researchers have discovered two genetic variants associated with substantial, rapid weight gain in people taking antipsychotic medications.

The researchers said the findings could eventually be used by doctors to identify which patients have the variations so they can be treated without the risk of weight gain, which can lead to obesity and health problems including diabetes and heart disease.

"Weight gain occurs in up to 40 percent of patients taking medications called second-generation or atypical antipsychotics, which are used because they're effective in controlling the major symptoms of schizophrenia," Dr. James Kennedy, of the Center for Addiction and Mental Health, in Toronto, said in a center news release.

Kennedy, senior author of a study published online recently in the journal Archives of General Psychiatry, pinpointed a variation near the melanocortin-4 receptor gene, which is known to be linked to obesity.

The study of patients in Europe and the United States being treated with atypical antipsychotics found that those with two copies of the variant gained about three times as much weight as those with one or no copies -- about 13 pounds vs. 4 pounds.

"The weight gain was associated with this genetic variation in all these groups, which included pediatric patients with severe behavior or mood problems, and patients with schizophrenia experiencing a first episode or who did not respond to other antipsychotic treatments," Dr. Daniel Muller, study co-author and Center for Addiction and Mental Health scientist, said in the news release.

"The results from our genetic analysis combined with this diverse set of patients provide compelling evidence for the role of this [melanocortin-4 receptor] variant," Muller said. "Our research group has discovered other gene variants associated with antipsychotic-induced weight gain in the past, but this one appears to be the most compelling finding thus far."

Kennedy and Muller also were involved in another study that identified a different variation near the melanocortin-4 receptor gene that was associated with weight gain in patients taking antipsychotic drugs. The study was published earlier this year in The Pharmacogenomics Journal.

Although the researchers found that the melanocortin-4 receptor gene variant was associated with rapid weight gain, the study did not prove a cause-and-effect relationship.

More information

The U.S. National Institute of Mental Health has more about mental-health medications.

-- Robert Preidt

SOURCE: Center for Addiction and Mental Health, news release, July 17, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Genes Linked to Osteoarthritis Identified
2. Study finds genes associated with hippocampal atrophy
3. New mechanism of bacterial pathogenesis discovered
4. Genes May Influence Reactions to Painkillers
5. Genes Might Help Some Smokers Kick the Habit
6. Genes predict if medication can help you quit smoking
7. Obesity genes may influence food choices, eating patterns
8. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
9. Strategy discovered to activate genes that suppress tumors and inhibit cancer
10. Genes Might Be Key to Parkinsons Spread
11. Living longer - variability in infection-fighting genes can be a boon for male survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes Influence Whether Psych Drugs Lead to Weight Gain
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... Facing medical ... father Ezra Clark is taking advantage of a new benefit for employees that is ... means a lot that the company supports me and other employees as new parents. ...
(Date:7/24/2017)... ... July 24, 2017 , ... ...      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins Will, ... celebrate the structural topping out of the new Destination Medical Building located ...
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... ... under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted ... of California Department of Health Care Services, will facilitate the development of a ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... already work hand-in-hand on an Innovation Collaboration program, have signed a five-year agreement ... and cost of the care members and patients receive. The agreement also signifies ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
(Date:7/10/2017)... July 10, 2017 Locus Biosciences Inc. today ... support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for ... leading Chinese Internet services provider, and joined by the ... infectious disease product programs targeting antibiotic resistant infections and ... Founded by Dr. Rodolphe Barrangou and Dr. ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
Breaking Medicine Technology: